Patent holdings for IPC class A61K 31/381

Total number of patents in this class: 3489

10-year publication summary

239
238
190
229
238
247
234
253
177
49
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2600
89
Antecip Bioventures II LLC
300
55
Janssen Pharmaceutica N.V.
3839
54
Astellas Pharma Inc.
1145
34
Novartis AG
11238
32
The Regents of the University of California
18943
32
Takeda Pharmaceutical Company Limited
2961
31
Sunovion Pharmaceuticals Inc.
326
29
Boehringer Ingelheim International GmbH
4629
26
Bristol-myers Squibb Company
5080
25
LTS Lohmann Therapie-Systeme AG
691
21
F. Hoffmann-La Roche AG
7958
20
The General Hospital Corporation
4517
18
Gilead Sciences, Inc.
1879
18
University of Pittsburgh - Of the Commonwealth System of Higher Education
2912
18
AstraZeneca AB
3042
17
Merck Patent GmbH
5909
17
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
762
17
Vertex Pharmaceuticals Incorporated
1581
16
Centre National de La Recherche Scientifique
9632
15
Other owners 2905